<DOC>
	<DOCNO>NCT01960075</DOCNO>
	<brief_summary>The primary objective determine effective and/or least effective treatment benzodiazepine-refractory status epilepticus ( SE ) among patient older 2 year . There three active treatment arm compare : fosphenytoin ( FOS ) , levetiracetam ( LEV ) , valproic acid ( VPA ) . The second objective comparison three drug respect secondary outcome . The final objective ensure trial informative treatment establish SE child describe effectiveness , safety , rate adverse reaction drug child .</brief_summary>
	<brief_title>Established Status Epilepticus Treatment Trial</brief_title>
	<detailed_description />
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Fosphenytoin</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Phenytoin</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Patient witness seize great 5 minute duration prior treatment study drug ; Patient receive adequate dose benzodiazepine . The last dose benzo administer 530 minute prior study drug administration . The dos may divide . ; continue recur seizure Emergency Department ; Age 2 year old Known pregnancy ; Prisoner ; Optout identification ; Treatment second line anticonvulsant ( FOS , PHT , VPA , LEV , phenobarbital agent define MoP ) episode SE ; Treatment sedatives anticonvulsant property benzodiazepine ( propofol , etomidate , ketamine agent define MoP ) ; Endotracheal intubation ; Acute traumatic brain injury ; Known metabolic disorder ; Known liver disease ; Known severe renal impairment ; Known allergy know contraindication FOS , PHT , LEV , VPA ; Hypoglycemia &lt; 50 mg/dL ; Hyperglycemia &gt; 400 mg/dL ; Cardiac arrest postanoxic seizure</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>status epilepticus , refractory , benzodiazepine , fosphenytoin , levetiracetam , valproic acid</keyword>
</DOC>